All Crowdz
Rezultatele cautarii
Vedeti tot
  • Conecteaza-te
    Conecteaza-te
    Inscrie-te
    Căutare
    Night Mode

Căutare

Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni

  • News Feed
  • EXPLORE
  • Pagini
  • Grupuri
  • Events
  • Blogs
  • Offers
  • Jobs
  • Courses
  • Postari
  • Blogs
  • Utilizatori
  • Pagini
  • Grupuri
  • Events
  • Shim Carter a adăugat un sunet Alte
    2026-01-21 07:26:56 -
    Myxoid Round Cell Liposarcoma (MRCLS) Drug Market – Precision Oncology Therapies, Rare Cancer Research & Clinical Pipeline
    "Global Executive Summary Myxoid Round Cell Liposarcoma (MRCLS) Drug Market: Size, Share, and Forecast CAGR Value The Global Myxoid Round Cell Liposarcoma (MRCLS) Drug Market size was valued at USD 10.61 billion in 2024 and is expected to reach USD 14.3 billion by 2032, at a CAGR of 3.81% during the forecast period While preparing the first class Myxoid Round Cell Liposarcoma (MRCLS) Drug...
    0 Commentarii 0 Distribuiri 456 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Ksh Dbmr a adăugat un sunet Networking
    2025-12-15 08:44:19 -
    Topoisomerase Inhibitors Market Advancing Precision Oncology Therapies
    Executive Summary Topoisomerase Inhibitors Market Size and Share Forecast CAGR Value Data Bridge Market Research analyses that the topoisomerase inhibitors will exhibit a CAGR of around 5.10% for the forecast period of 2022-202 This Topoisomerase Inhibitors Market Research Report also conducts analysis on consumption of the market, key players involved, sales, price, revenue, and...
    0 Commentarii 0 Distribuiri 721 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Subhayan Mayra a adăugat un sunet Alte
    2026-04-20 11:24:57 -
    Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034
    According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...
    0 Commentarii 0 Distribuiri 66 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
© 2026 All Crowdz Romaian
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Termeni Confidențialitate Contacteaza-ne Director